DK0713527T3 - Fungicide fremgangsmåder og sammensætninger til drab af gær og sporulære mikroorganismer - Google Patents

Fungicide fremgangsmåder og sammensætninger til drab af gær og sporulære mikroorganismer

Info

Publication number
DK0713527T3
DK0713527T3 DK94924525T DK94924525T DK0713527T3 DK 0713527 T3 DK0713527 T3 DK 0713527T3 DK 94924525 T DK94924525 T DK 94924525T DK 94924525 T DK94924525 T DK 94924525T DK 0713527 T3 DK0713527 T3 DK 0713527T3
Authority
DK
Denmark
Prior art keywords
compositions
methods
carbon atoms
antimicrobial activity
activity enhancing
Prior art date
Application number
DK94924525T
Other languages
English (en)
Inventor
Robert C Allen
Original Assignee
Exoxemis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exoxemis Inc filed Critical Exoxemis Inc
Application granted granted Critical
Publication of DK0713527T3 publication Critical patent/DK0713527T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/082—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances in combination with specific enzymes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/12—Non-macromolecular oxygen-containing compounds, e.g. hydrogen peroxide or ozone
    • A61L12/124—Hydrogen peroxide; Peroxy compounds
    • A61L12/126—Hydrogen peroxide; Peroxy compounds neutralised with catalase or peroxidase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/38—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A61L2/186—Peroxide solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/22—Phase substances, e.g. smokes, aerosols or sprayed or atomised substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0065—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01007—Peroxidase (1.11.1.7), i.e. horseradish-peroxidase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/02—Oxidoreductases acting on a peroxide as acceptor (1.11) with H2O2 as acceptor, one oxygen atom of which is incorporated into the product (1.11.2)
    • C12Y111/02002—Myeloperoxidase (1.11.2.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/106—Halogens or compounds thereof, e.g. iodine, chlorite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/11—Peroxy compounds, peroxides, e.g. hydrogen peroxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/408—Virucides, spermicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK94924525T 1993-08-02 1994-08-01 Fungicide fremgangsmåder og sammensætninger til drab af gær og sporulære mikroorganismer DK0713527T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/100,780 US5389369A (en) 1991-02-21 1993-08-02 Halo peroxidase containing compositions for killing yeast and sporular microorganisms
PCT/US1994/008608 WO1995004135A1 (en) 1993-08-02 1994-08-01 Fungicidal methods and compositions for killing yeast and sporular microorganisms

Publications (1)

Publication Number Publication Date
DK0713527T3 true DK0713527T3 (da) 2001-12-10

Family

ID=22281505

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94924525T DK0713527T3 (da) 1993-08-02 1994-08-01 Fungicide fremgangsmåder og sammensætninger til drab af gær og sporulære mikroorganismer

Country Status (11)

Country Link
US (3) US5389369A (da)
EP (1) EP0713527B1 (da)
JP (1) JP3723209B2 (da)
KR (1) KR100325901B1 (da)
CN (1) CN1081672C (da)
AT (1) ATE208563T1 (da)
AU (1) AU679777B2 (da)
CA (1) CA2167525C (da)
DE (1) DE69429094T2 (da)
DK (1) DK0713527T3 (da)
WO (1) WO1995004135A1 (da)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756090A (en) * 1991-02-21 1998-05-26 Eoe, Inc. Oxygen activatable formulations for disinfection or sterilization
US5389369A (en) * 1991-02-21 1995-02-14 Exoxemis, Inc. Halo peroxidase containing compositions for killing yeast and sporular microorganisms
AU3070395A (en) * 1994-07-22 1996-02-22 Alcon Laboratories, Inc. Use of low molecular weight amino acids in ophthalmic compositions
AU2635097A (en) * 1996-04-29 1997-11-19 Novo Nordisk A/S Non-aqueous, liquid, enzyme-containing compositions
AU6469698A (en) * 1997-03-24 1998-10-20 Clorox Company, The A chloroperoxidase enzyme system for generating hypochlorous acid and hypochlorite (in situ)
US6058940A (en) * 1997-04-21 2000-05-09 Lane; Kerry Scott Method and system for assay and removal of harmful toxins during processing of tobacco products
US6637438B1 (en) * 1997-04-21 2003-10-28 Kerry Scott Lane Method for assay and removal of harmful toxins during processing of tobacco products
US6251386B1 (en) * 1997-08-14 2001-06-26 Novo Nordisk A/S Antimicrobial composition containing a haloperoxidase, a hydrogen peroxide source, a halide source and an ammonium source
US6025186A (en) * 1997-08-14 2000-02-15 Novo Nordisk A/S Reduction of malodor
US6592867B2 (en) * 1998-11-09 2003-07-15 Novozymes A/S Antimicrobial composition containing an oxidoreductase and an enhancer of the N-hydroxyanilide-type
US7868162B2 (en) * 1998-12-30 2011-01-11 Lakewood-Amedex, Inc. Antimicrobial and antiviral compounds and methods for their use
US6627215B1 (en) * 1998-12-30 2003-09-30 Oligos Etc. Inc. Devices for improved wound management
US7767216B2 (en) * 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US6506803B1 (en) 1999-04-28 2003-01-14 Regents Of The University Of Michigan Methods of preventing and treating microbial infections
US7655252B2 (en) 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US6559189B2 (en) 1999-04-28 2003-05-06 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
US8232320B2 (en) * 1999-04-28 2012-07-31 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US6635676B2 (en) 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
DE10028998A1 (de) * 2000-02-17 2001-08-23 Bode Chemie Gmbh & Co Kg Reinigungs- und Desinfektionssysteme für medizinische Instrumente
US20040086453A1 (en) * 2001-01-22 2004-05-06 Howes Randolph M. Compositions, methods, apparatuses, and systems for singlet oxygen delivery
US7138035B2 (en) * 2001-05-08 2006-11-21 National Starch And Chemical Investment Holding Corporation Process for the selective modification of carbohydrates by peroxidase catalyzed oxidation
EP2545937A1 (en) * 2001-06-05 2013-01-16 The Regents Of The University Of Michigan Nanoemulsion vaccines
AU2002347018A1 (en) 2001-12-04 2003-06-17 Novozymes A/S Methods for killing spores
SE0200876L (sv) * 2002-03-22 2003-09-23 Krister Tano Nässpray mot öroninflammationer
US20040126369A1 (en) * 2002-12-30 2004-07-01 Richard Payne Delivery of peroxide-generating enzymes to the vaginal tract
US20050208083A1 (en) * 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
US20050100601A1 (en) * 2003-11-07 2005-05-12 Viratox, L.L.C. Virucidal activities of cetylpyridinium chloride
KR20070011394A (ko) * 2004-03-23 2007-01-24 더 클로록스 캄파니 차아염소산염의 희석법
WO2006110699A1 (en) * 2005-04-11 2006-10-19 Nanobio Corporation Quaternary ammonium halides for treatment of infectious conditions
US20060289354A1 (en) * 2005-06-15 2006-12-28 Buckman Laboratories International, Inc. Method and composition to control the growth of microorganisms in aqueous systems and on substrates
CA2618974C (en) * 2005-08-09 2014-01-28 Nanobio Corporation Nanoemulsion compositions having anti-inflammatory activity
US7797337B2 (en) * 2005-09-29 2010-09-14 Scenera Technologies, Llc Methods, systems, and computer program products for automatically associating data with a resource as metadata based on a characteristic of the resource
US20070264355A1 (en) * 2005-12-14 2007-11-15 Binary, Llc Binary compositions and methods for sterilization
US20070197388A1 (en) * 2006-02-22 2007-08-23 Buckman Laboratories International, Inc. Haloperoxidase treatment to control algae
US20070237756A1 (en) * 2006-04-06 2007-10-11 Purac Biochem B.V. Antimicrobial preparations
US20080038295A1 (en) * 2006-04-13 2008-02-14 Regents Of The University Of Michigan Compositions and methods for orthopox virus vaccination
US10138279B2 (en) 2006-04-13 2018-11-27 Regents Of The University Of Michigan Compositions and methods for Bacillus anthracis vaccination
US9839685B2 (en) * 2006-04-13 2017-12-12 The Regents Of The University Of Michigan Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
WO2008021349A1 (en) * 2006-08-16 2008-02-21 Novartis Ag Temporal photo-bleaching of colored lens care solutions and use thereof
CA2673497A1 (en) * 2006-10-10 2008-04-17 Laclede, Inc. Methods and compositions for the treatment of vaginal diseases employing peroxide-producing enzymes and peroxidases
WO2008103416A1 (en) * 2007-02-21 2008-08-28 Capps Charles L Synergistic enhancement of calcium propionate
US8747872B2 (en) * 2007-05-02 2014-06-10 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
EP2217074A1 (en) * 2007-10-23 2010-08-18 Novozymes A/S Methods for killing spores and disinfecting or sterilizing devices
US20090148342A1 (en) * 2007-10-29 2009-06-11 Bromberg Steven E Hypochlorite Technology
US8734867B2 (en) 2007-12-28 2014-05-27 Liveleaf, Inc. Antibacterial having an extract of pomegranate combined with hydrogen peroxide
JP5490020B2 (ja) * 2008-01-24 2014-05-14 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状カルバゼート及びセミカルバジドインヒビター
WO2009100456A2 (en) * 2008-02-08 2009-08-13 Prothera, Inc. Inhibition and treatment of gastrointestinal biofilms
JP5558458B2 (ja) * 2008-03-20 2014-07-23 タノメド・アクチボラゲット 普通感冒の治療用の医薬の製造における物質の使用
US8945540B2 (en) * 2008-05-09 2015-02-03 Exoxemis, Inc. Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof
US9415006B2 (en) * 2008-05-23 2016-08-16 The Regents Of The University Of Michigan Immunogenic compositions comprising nanoemulsion and hepatitis B virus immunogen and methods of using the same
AU2009296458A1 (en) 2008-09-26 2010-04-01 Nanobio Corporation Nanoemulsion therapeutic compositions and methods of using the same
WO2010046142A2 (en) * 2008-10-23 2010-04-29 Getinge Disinfection Ab A method of obtaining high level disinfection in a washer disinfector, and a washer disinfector
EP2376089B1 (en) 2008-11-17 2018-03-14 The Regents of the University of Michigan Cancer vaccine compositions and methods of using the same
PL2403938T3 (pl) * 2009-03-04 2020-09-21 Liveleaf, Inc. Sposób i materiał do miejscowo aktywowanego kompleksowania cząsteczek biologicznych
EP2424379A2 (en) * 2009-04-28 2012-03-07 DSM IP Assets B.V. A method for improving a bean-based product
WO2010148111A1 (en) 2009-06-16 2010-12-23 The Regents Of The University Of Michigan Nanoemulsion vaccines
US20110200683A1 (en) * 2010-02-16 2011-08-18 Piper Medical, Inc Hydrogen peroxide solution producing first aid substance, packaging, and treatment
FR2971405B1 (fr) 2011-02-11 2014-05-30 Marc Bonneau Dispositif et procede de decontamination et de sterilisation, notamment pour des produits alimentaires ou agricoles, des fluides ou des materiels industriels
US9192635B2 (en) 2011-06-24 2015-11-24 Liveleaf, Inc. Method of treating damaged mucosal or gastrointestinal tissue by administering a composition comprising a mixture of pomegranate and green tea extracts and releasably bound hydrogen peroxide
US8722040B2 (en) 2011-06-24 2014-05-13 Liveleaf, Inc. Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites
AU2012281172B2 (en) * 2011-07-11 2016-11-17 Exoxemis, Inc. Eosinophil peroxidase compositions and methods of their use
US8716351B1 (en) 2012-12-23 2014-05-06 Liveleaf, Inc. Methods of treating gastrointestinal spasms
AU2014264531A1 (en) 2013-05-08 2015-09-24 Novozymes A/S Animal feed enzymes
US9814234B2 (en) * 2014-01-14 2017-11-14 Exoxemis, Inc. Bioactive heme-haloperoxidase compositions and methods of their use
US10463754B2 (en) * 2014-04-28 2019-11-05 American Sterilizer Company Process for decontaminating or sterilizing an article
EP3245871A1 (en) 2014-04-30 2017-11-22 Matoke Holdings Limited Antimicrobial compositions
ES2924988T3 (es) 2014-10-10 2022-10-13 Univ Michigan Regents Composiciones con nanoemulsiones para prevenir, inhibir o eliminar una enfermedad alérgica e inflamatoria
MX2018002533A (es) 2015-09-29 2018-06-27 Kimberly Clark Co Composicion sinergica para el mantenimiento de un equilibrio saludable de la microflora.
CN109414485B (zh) * 2016-05-27 2022-08-12 埃欧艾米斯公司 用于抑制脂多糖和脂质a的髓过氧化物酶组合物和方法
JP7112706B2 (ja) * 2017-01-16 2022-08-04 御木本製薬株式会社 抗菌性組成物並びに該抗菌性組成物を配合した皮膚外用剤
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
WO2020014493A1 (en) * 2018-07-13 2020-01-16 Allen Robert C Haloperoxidase compositions and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2679533A (en) * 1951-11-03 1954-05-25 California Research Corp Addition products of halogen and quaternary ammonium germicides and method for making the same
GB2108387B (en) * 1979-12-28 1984-03-21 Green Cross Corp A pharmaceutical composition containing myeloperoxidase
US4473550A (en) * 1981-01-16 1984-09-25 Rosenbaum Robert S Bactericidal compositions and methods
JPS592686A (ja) * 1982-06-25 1984-01-09 Green Cross Corp:The ミエロペルオキシダ−ゼの粉末製剤
US4588586A (en) * 1983-01-03 1986-05-13 Kessler Jack H Method for disinfecting a contact lens
US4576817A (en) * 1984-06-07 1986-03-18 Laclede Professional Products, Inc. Enzymatic bandages and pads
US4937072A (en) * 1986-05-12 1990-06-26 Kessler Jack H In situ sporicidal disinfectant
DK501686A (da) * 1986-10-20 1988-04-21 Otto Melchior Poulsen Enzymholdigt, baktericidt middel samt tandplejemidler og saarbehandlingsmidler, som indeholder det
US4996146A (en) * 1987-02-20 1991-02-26 Kessler Jack H Rapid sterilization enzymatic process with persistence
FR2632525B1 (fr) * 1988-06-14 1992-07-31 Improbio Application therapeutique de la myeloperoxydase humaine
WO1990003185A1 (en) * 1988-09-28 1990-04-05 Ideon Corporation Combination enzyme immunotherapeutics
FR2646777B1 (fr) * 1989-05-12 1993-09-03 Bio Serae Lab Procede de preparation d'un produit particulaire antimicrobien, produit antimicrobien obtenu et applications
US5389369A (en) * 1991-02-21 1995-02-14 Exoxemis, Inc. Halo peroxidase containing compositions for killing yeast and sporular microorganisms

Also Published As

Publication number Publication date
JP3723209B2 (ja) 2005-12-07
DE69429094D1 (de) 2001-12-20
EP0713527A1 (en) 1996-05-29
AU7477294A (en) 1995-02-28
JPH09503752A (ja) 1997-04-15
KR100325901B1 (ko) 2002-06-29
CA2167525C (en) 2006-11-28
CN1128044A (zh) 1996-07-31
WO1995004135A1 (en) 1995-02-09
DE69429094T2 (de) 2002-03-21
CA2167525A1 (en) 1995-02-09
US5451402A (en) 1995-09-19
ATE208563T1 (de) 2001-11-15
US5389369A (en) 1995-02-14
EP0713527A4 (en) 1998-01-07
CN1081672C (zh) 2002-03-27
AU679777B2 (en) 1997-07-10
EP0713527B1 (en) 2001-11-14
US5510104A (en) 1996-04-23

Similar Documents

Publication Publication Date Title
DK0713527T3 (da) Fungicide fremgangsmåder og sammensætninger til drab af gær og sporulære mikroorganismer
KR100449283B1 (ko) 소독 또는 멸균을 위한 산소활성 제조물
AU2002322298A1 (en) Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
ATE298507T1 (de) Percarbonsäurezusammensetzungen und verwendung gegen mikrobielle sporen
DE69831506D1 (en) 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
BR9813248A (pt) Processos para limitar crescimento de um microorganismo, para desinfecção de uma superfìcie e para limitar o crescimento de um vìrus, uma bactéria e/ou um fungo, composição, e, composto contendo metal
CA2245174A1 (en) Treatment of contact lenses with an aqueous solution including sulfobetaine compounds
MX2010012163A (es) Composiciones para mejorar la actividad antibacteriana de mieloperoxidasa y metodos de uso de las mismas.
IL122248A0 (en) Use of nisin for treating an infection
CA2309172A1 (en) Aminobiguanides to disinfect contact lenses and preserve pharmaceutical compositions
AU5993698A (en) Additive composition for plant protection
ATE252833T1 (de) Biozidzusammensetzung und diese verwendendes sterilisationsverfahren
NZ293691A (en) Use of a medicament containing an anilide compound for treatment of type i allergic diseases
TR200101433T2 (tr) Enfeksiyonların tedavisinde fosfonoformik asit türevlerinin kullanımı.
MX9605346A (es) Compuesto antimicrobianos con velocidad rapida de eliminacion.
AU4390699A (en) Disinfecting preparation containing chlorine in alcohol
DE69320040D1 (de) Halogenierte 4'-methoxyacetophenone als mikrobizide und konservierungsmittel
NZ503027A (en) Use of rifamycin derivative for treating mastitis in a domestic animal
KR20030069973A (ko) 청정 농산물의 생산을 위한 과산화수소 발생제의 이용
DE60105262D1 (de) ZUSAMMENSETZUNGEN enthaltend Monoperphthalatsäure ZUR BEHANDLUNG VON KONTAKTLINSEN
MX9603754A (es) Compuestos, de amplio espectro, activos contra microbios.
RU93000694A (ru) "стагифор" - лосьон, составное вещество в форме лосьона для борьбы с педикулезом